Clinical Trial Update: MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating MT10109L for treating lateral canthal lines, with or without concurrent glabellar line treatment, has completed and posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Lines
• Lateral Canthal Lines

Drugs mentioned

• MT10109L

Snippet

Sponsor: Medy-Tox | Conditions: Lateral Canthal Lines, Glabellar Lines | Phase 3 | Status: COMPLETED | Results posted: 2023-07-17